Acid Pump Inhibitors
It is indicated for the treatment of the following.
(a) Acute duodenal
(b) Acute benign
Erosive or Ulcerative Gastro-esophageal Reflux Disease (GERD).
Reflux Disease Long-term Management.
(f) For the
eradication of Helicobacter pylori in patients with peptic
ulcer disease in combination with appropriate antibacterial
Promto (Rabeprazole Sodium), a substituted
benzimidazole, is a proton pump inhibitor that inhibits gastric
acid secretion. It belongs to a new class of antisecretory
compound (substituted benzimidazole
proton-pump inhibitor) that does not exhibit anticholinergic
or histamine H2 - receptor antagonist properties, but suppresses
gastric acid secretion by inhibiting the gastric H+/K+
ATPase at the parietal cell.
Tablet 10mg and 20mg